Aquestive therapeutics corporate presentation

Github powerapps components

Corporate News, FDA. ... Aquestive Therapeutics, Inc. (NASDAQ: AQST), ... In addition to the poster presentations, Aquestive will host a Scientific Exhibit on Monday, December 9th from 8:00 am ... The Investor Relations website contains information about Nabriva Therapeutics's business for stockholders, potential investors, and financial analysts. Subscribe for Email Alerts. Subscribe to RSS feed. List View; Grid View Aquestive Therapeutics, Inc. (NASDAQ: AQST) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure Aquestive Therapeutics, Inc. is furnishing the investor presentations attached ... 1 month Aquestive Therapeutics (AQST) Investor ... Market Insider is a business news aggregator for traders and investors that proposes to you the latest financial ... The FDA granted AQST-108 Fast Track designation in August 2020.About Aquestive Therapeutics Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve ... Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant™ (diazepam) Buccal Film for Management of Seizure Clusters * Complete Response Letter cites exposure levels (Cmax) in certain weight groups * No additional clinical studies anticipated by Aquestive * No Clinical Safety issues or Non-Clinical Chemistry, Manufacturing and Controls (CMC) issues identified ... Find the latest Aquestive Therapeutics, Inc. (AQST) stock quote, history, news and other vital information to help you with your stock trading and investing. Jul 15, 2020 · WARREN, N.J., July 15, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address... The Investor Relations website contains information about Nabriva Therapeutics's business for stockholders, potential investors, and financial analysts. 1 month Aquestive Therapeutics (AQST) Investor ... Market Insider is a business news aggregator for traders and investors that proposes to you the latest financial ... 17 hours ago · This presentation has been prepared by Stoke Therapeutics, Inc. ("Stoke" or "our") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by the presenter or Stoke or any officer, director, employee, agent or advisor of Stoke. Corporate Presentation – August 2020 1.1 MB. ... Images of individuals were purchased by Aquestive® Therapeutics and are intended to model real patient scenarios. The Investor Relations website contains information about Aquestive Therapeutics's business for stockholders, potential investors, and financial analysts. Aquestive Therapeutics, Inc. is located in Warren, NJ, United States and is part of the Drug Stores Industry. Aquestive Therapeutics, Inc. has 277 total employees across all of its locations and generates $52.61 million in sales (USD). There are 4 companies in the Aquestive Therapeutics, Inc. corporate family. Feb 20, 2020 · WARREN, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products... Jun 16, 2020 · WARREN, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address ... Aquestive Therapeutics, Inc. (NASDAQ: AQST) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure Aquestive Therapeutics, Inc. is furnishing the investor presentations attached ... Aquestive Therapeutics Reaffirms Full Year 2019 Revenue Guidance and Will Announce Third Quarter 2019 Financial Results and Recent Business Highlights on November 6, 2019 09.30.2019 Aquestive Therapeutics Announces Successful Completion of Phase 1 Trial for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) May 07, 2020 · WARREN, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that management will present at the 2020 RBC Capital Markets Global Healthcare Conference to be held virtually on May 19-20. Sep 25, 2020 · Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant™ (diazepam) Buccal Film for Management of Seizure Clusters. Posted by: GlobeNewswire in Top News 10 days ago Sep 25, 2020 · About Aquestive Therapeutics Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Nov 26, 2019 · Aquestive Therapeutics Announces Poster Presentations of Data on Libervant™ (diazepam) Buccal Film at American Epilepsy Society 2019 Annual Meeting PRESS RELEASE GlobeNewswire Nov. 26, 2019, 11 ... Get the latest Aquestive Therapeutics, Inc. (AQST) stock news and headlines to help you in your trading and investment decisions. Mar 11, 2020 · Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Aquestive is advancing proprietary products and late-stage product candidates to treat CNS conditions and provide alternatives to invasively administered standard of care therapies. Corporate Presentation – September 2020 1.2 MB. ... Images of individuals were purchased by Aquestive® Therapeutics and are intended to model real patient scenarios. WARREN, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that it will report results for the fourth quarter and full year ended December 31, 2019 and provide a business update on Thursday, March 12, 2020 before the market open. WARREN, N.J., April 21, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (AQST) , a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that it will report results for the first quarter ended March 31, 2020 and provide a business update after market close on Tuesday, May 5, 2020. Sep 30, 2020 · Shares of Aquestive Therapeutics (AQST) opened the week in the worst possible way, cratering 42% over the past two trading sessions. The sharp drop came following Aquestive’s announcement it had ... May 07, 2020 · WARREN, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that management will present at the 2020 RBC Capital Markets Global Healthcare Conference to be held virtually on May 19-20. May 05, 2020 · Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Aquestive is advancing proprietary products...